Valvular Heart Disease Patients on Edoxaban or Warfarin in the ENGAGE AF-TIMI 48 Trial
De Caterina, Raffaele, MD, PhD, Renda, Giulia, MD, PhD, Carnicelli, Anthony P., MD, Nordio, Francesco, PhD, Trevisan, Marco, MSc, Mercuri, Michele F., MD, Ruff, Christian T., MD, MPH, Antman, Elliott M., MD, Braunwald, Eugene, MD, Giugliano, Robert P., MD, SM
Published in Journal of the American College of Cardiology (21.03.2017)
Published in Journal of the American College of Cardiology (21.03.2017)
Get full text
Journal Article
Mortality in Patients With Atrial Fibrillation Randomized to Edoxaban or Warfarin: Insights from the ENGAGE AF-TIMI 48 Trial
Giugliano, Robert P., MD, SM, Ruff, Christian T., MD, MPH, Wiviott, Stephen D., MD, Nordio, Francesco, PhD, Murphy, Sabina A., MPH, Kappelhof, Johannes AN., BSc, Shi, Minggao, PhD, Mercuri, Michele, MD, Antman, Elliott M., MD, Braunwald, Eugene, MD
Published in The American journal of medicine (01.08.2016)
Published in The American journal of medicine (01.08.2016)
Get full text
Journal Article
Cost-effectiveness of edoxaban vs warfarin in patients with atrial fibrillation based on results of the ENGAGE AF–TIMI 48 trial
Magnuson, Elizabeth A., ScD, Vilain, Katherine, MPH, Wang, Kaijun, PhD, Li, Haiyan, MS, Kwong, Winghan J., PharmD, PhD, Antman, Elliott M., MD, Ruff, Christian T., MD, MPH, Giugliano, Robert P., MD, SM, Cohen, David J., MD, MSc
Published in The American heart journal (01.12.2015)
Published in The American heart journal (01.12.2015)
Get full text
Journal Article
Non-Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation
Plitt, Anna, Ruff, Christian T, Giugliano, Robert P
Published in Hematology/oncology clinics of North America (01.10.2016)
Published in Hematology/oncology clinics of North America (01.10.2016)
Get more information
Journal Article
Systemic, noncerebral, arterial embolism in 21,105 patients with atrial fibrillation randomized to edoxaban or warfarin: Results from the Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction Study 48 trial
Geller, Bram J., MD, Giugliano, Robert P., MD, SM, Braunwald, Eugene, MD, Murphy, Sabina A., MPH, Hanyok, James J., PharmD, Jin, Jianqing, PhD, Mercuri, Michele, MD, PhD, Antman, Elliott M., MD, Ruff, Christian T., MD, MPH
Published in The American heart journal (01.10.2015)
Published in The American heart journal (01.10.2015)
Get full text
Journal Article
Edoxaban vs warfarin in patients with nonvalvular atrial fibrillation in the US Food and Drug Administration approval population: An analysis from the Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation–Thrombolysis in Myocardial Infarction 48 (ENGAGE AF–TIMI 48) trial
Eisen, Alon, MD, Giugliano, Robert P., MD, SM, Ruff, Christian T., MD, MPH, Nordio, Francesco, PhD, Gogia, Harinder S., MD, Awasty, Vivek R., MD, Henderson, David A., MD, Mercuri, Michele F., MD, PhD, Rutman, Howard, MD, Antman, Elliott M., MD, Braunwald, Eugene, MD
Published in The American heart journal (01.02.2016)
Published in The American heart journal (01.02.2016)
Get full text
Journal Article
Central versus local adjudication of myocardial infarction in a cardiac biomarker trial
Smith, Stephen W., MD, Diercks, Deborah B., MD, MSc, Nagurney, John T., MD, MPH, Hollander, Judd E., MD, Miller, Chadwick D., MD, MS, Schrock, Jon W., MD, Singer, Adam J., MD, Apple, Fred S., PhD, McCullough, Peter A., MD, MPH, Ruff, Christian T., MD, MPH, Sesma, Arturo, PhD, Peacock, W. Frank, MD
Published in The American heart journal (01.03.2013)
Published in The American heart journal (01.03.2013)
Get full text
Journal Article